feed,title,long_url,short_url
SeekingAlpha,Veru pops 5% after fiscal Q2 results; FC2 prescription revenues climbs 48%,https://seekingalpha.com/news/3695125,
SeekingAlpha,Palantir: Multi-Year Revenue Growth Visibility And Strong Free Cash Flow,https://seekingalpha.com/article/4427748,
